The Role of Mold-Active Prophylaxis in High-Risk Patients

Only eight patients or 3% developed evasive-fungal disease, they had three cases of pneumocystis, three invasive molds, and two invasive yeast infections. And these patients did not receive any routine yeast or mold-proofial access. So I think it really depends on where you practice and what your institutional rates of evasive- fungal infections are.